JP focuses on growth equity investments in healthcare, including healthcare services, pharma services, healthcare IT, medical devices, and digital health.

Prior to joining Norwest, JP interned with Summit Partners’ healthcare team, Optum Ventures, and Cigna.

JP graduated from UC Berkeley, with a B.A. in Economics.

Irem brings over a decade of investing and operating experience across various stages of healthcare services and healthcare technology companies. At Norwest, she focuses on venture and growth equity opportunities across healthcare services, healthcare IT, pharma services and digital health.

Prior to joining Norwest, Irem worked at Summit Partners where she focused on healthcare growth stage businesses and was a board member or observer for four companies across risk-based providers and healthcare tech-enabled services. She was also a Principal at McKesson Ventures where she led investments in value-based care and pharma IT/services. Irem helped source or served as a board observer for Landmark Health (acquired by Optum), Aledade, IVX Health (recapped by Great Hill Partners), OncoHealth (formerly Oncology Analytics), SHYFT Analytics (acquired by Medidata), Aetion, Curana Health (formerly AllyAlign), Komodo Health, Kyruus and Evariant (acquired by Healthgrades).

Prior to joining McKesson, Irem was part of the founding team of Burd Health where she led the development and implementation of value-based initiatives for self-insured organizations across network management, pharmacy benefit management, and wellness products. She also served in product and business development roles with healthcare startups Omada Health and Caremerge (acquired by VoiceFriend) and was an intern at Andreessen Horowitz where she sourced digital health investments.

Irem started her career as an investment associate at Madison Dearborn Partners and an investment banking analyst in the Healthcare Group at Bank of America Merrill Lynch where she analyzed mergers and acquisitions for companies across life sciences, medical devices and healthcare services.

Irem holds a BS in biomedical engineering and economics, magna cum laude, from Duke University and an MBA from the Stanford Graduate School of Business, where she was an Arbuckle Leadership Fellow and Co-President of the Healthcare Club.

Dr. Zack Scott previously served on the board of directors for Cianna Medical, Coherex Medical, Evidation Health, Providence Medical Technology, Respicardia, Spiration, and Syapse.

Prior to joining Norwest, Zack was the co-founder and managing partner of Revelation Partners, a dedicated secondary investor specializing in shareholder liquidity and growth capital for healthcare companies. During his time at Revelation Partners, he made notable investments in Omada Health, iRhythm Technologies (IPO), SetPoint Medical, and Respicardia (acquired by Zoll Medical).

Before working in private equity, Zack was a General Surgery resident at Oregon Health & Science University in Portland, Oregon. He earned his M.D. from the University of Texas Health Science Center at San Antonio where he was a member of the AOA Medical Honors Society, and subsequently earned an M.B.A. with a specialized certificate in Health Sector Management from The Fuqua School of Business at Duke University where he was a Fuqua Scholar.

Brian is an experienced life sciences investor who focuses on early to mid-stage companies.

Prior to joining Norwest, Brian worked at Blackstone Life Sciences, where he helped lead over $1.5B of investments across biotech, medical devices, and diagnostics. He was a Board Observer or Alliance Committee Member at 5 companies, working closely with management teams on clinical trials, FDA approval process, and commercial strategy. Brian was previously an Engagement Manager at McKinsey & Company, where he advised companies across the healthcare industry.

Brian has a medical degree from Stanford and MBA from Harvard. His research on prostate cancer, diabetic macular edema, and patient safety has been published in multiple peer-review journals.

Ehi focuses on venture opportunities in the healthcare sector, including therapeutics, medical devices, diagnostics, digital health and health tech IT and services.

Ehi was previously at McKinsey & Company’s Life Sciences practice, where he advised clients in the pharmaceutical and medical products industries on corporate strategy, M&A and R&D.

Ehi has an MD and a PhD from the MSTP at Washington University School of Medicine. During his PhD, he published papers on the genetic mechanisms of risk in congenital heart disease. He also has bachelor’s degrees in Biology and Chemistry from Emory University, where he graduated with highest honors.

Joe focuses on growth equity investments in healthcare, including healthcare services, pharma services, healthcare IT, medical devices, and digital health.

Joe joins Norwest from Evercore in New York, where he worked as a senior associate on the Healthcare Services & Technology Equity Research team.

Joe graduated from Georgetown University as a George F. Baker Scholar with a bachelor’s degree in Government and History.

Michael focuses on growth equity investments across a wide range of sectors including technology, business services, internet and consumer.

Prior to joining Norwest full-time, Michael was a growth equity intern where he researched and presented investment opportunities.

Michael received a B.A. in economics from Harvard College, where he was a three-time captain of the varsity swim team.

Tiba joins Norwest as a biotech investor with 20+ years of research and investment experience.

Based in the San Francisco office, she invests in healthcare with a focus on early to mid-stage companies within the therapeutics sector.

Prior to joining Norwest, Tiba spent over ten years at Novo Holdings A/S, one of the top life sciences investment firms, with offices in the US and Europe. In her previous role, she was responsible for the deployment of ~280M of capital in private biotech, MedTech and HCIT companies. Earlier in her career Tiba was a banker focused on M&A, licensing, and financing transactions involving biotech/pharma.

Tiba attended the University of California Irvine where she received a Bachelor of Science degree in Physics with a Biomedical concentration. She also holds a Ph.D. in Biophysics from the University of California San Francisco, where she also did her Postdoctoral Fellowship. Tiba is also a published author of scientific articles and book chapters in rational drug design.

Suraj focuses on venture opportunities in the healthcare sector, including digital health and healthcare IT, technology-enabled healthcare services, medical devices, diagnostics, and biopharma.

Prior to joining Norwest, Suraj was a senior business analyst in the healthcare practice at Kearney, a global management consulting firm. Prior to Kearney, he held a business development role at UnitedHealthGroup.

Suraj graduated with honors from Johns Hopkins University with a bachelor of science in biomedical engineering and a minor in computer science. While at Hopkins, Suraj directed its nationally recognized medical hackathon, MedHacks, and led A-Level Capital, a student-run venture fund investing in companies founded by Hopkins students, alumni, and faculty.

Sonia focuses on growth equity investments in healthcare, including healthcare services, pharma services, healthcare IT, medical devices, and digital health.

Prior to joining Norwest, Sonia was an analyst in the healthcare investment banking group at J.P. Morgan. In this role, she executed numerous financings and M&A transactions and advised companies across the healthcare industry.

Sonia graduated from the Jerome Fisher Program in Management & Technology at the University of Pennsylvania, where she earned a bachelor of science in economics with a concentration in finance from the Wharton School and a bachelor of applied science in Computer Science from the School of Engineering.